Auraptene Analog Promotes Osteoblast Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current agents and compositions do not effectively promote osteoblast differentiation, which is crucial for bone formation, and lack safety and efficacy in preventing and treating osteopenic diseases.
Innovation Solution
Auraptene and its coumarin analogues, naturally occurring compounds found in citrus fruits, are used to create an agent that promotes osteoblast differentiation, offering a safe and effective solution for bone formation and treatment of osteopenic diseases, comparable to the action of Bone Morphogenetic Protein-2 (BMP-2) but with lower production costs and stability issues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If BMP-2 is used to promote osteoblast differentiation, then bone formation is enhanced, but production cost increases and stability issues occur
Solution Approach 1:
The patent replaces the expensive and unstable BMP-2 protein with a cheap, stable coumarin compound (auraptene or analog) that can be easily manufactured from citrus fruits. The coumarin compound achieves comparable osteoblast differentiation promotion without the production cost and stability issues of BMP-2, effectively using a simple, inexpensive natural product to substitute a complex, expensive biologic.
2Reliability
If conventional agents are used for bone formation, then some bone metabolism effects are achieved, but osteoblast differentiation promotion is insufficient
Solution Approach 1:
The patent identifies specific coumarin compounds (auraptene and analogs with particular molecular structures) that have enhanced osteoblast differentiation activity compared to conventional agents. By optimizing the chemical structure parameters of the coumarin compound (specific R1-R6 substituents), the patent achieves superior efficacy in promoting osteoblast differentiation while maintaining safety.
Data Source
AI summary
Agents or pharmaceutical compositions for promoting osteoblast differentiation include purified auraptene or coumarin analogs thereof represented by the following formula 1:wherein R1 represents a hydrogen, a hydroxy, a methoxy, a methyl, an ethyl, a propyl, a carboxyl, a carboxymethyl, or a carboxyethyl; R2 represents a hydrogen, a hydroxy, a methoxy, a methyl, an ethyl, a propyl, a carboxyl, a carboxymethyl, a carboxyethyl or a coumarinyl; R3 represents a hydrogen, a hydroxy, a methoxy, a methyl, an ethyl, a propyl, a carboxyl, a carboxymethyl or a carboxyethyl; and R4 represents a hydrogen, a C1-C15 liner or branched alkyl, an alkenyl, an alkadienyl or an alkatrienyl.